HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

CUSIP: 40637H109

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / Common Stock
Shares outstanding
123,650,000
Total 13F shares
94,411,049
Share change
+3,013,922
Total reported value
$1,348,555,169
Put/Call ratio
70%
Price per share
$14.28
Number of holders
137
Value change
+$51,544,544
Number of buys
80
Number of sells
58

Quarterly Holders Quick Answers

What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q1 2015

As of 31 Mar 2015, HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 94,411,049 shares. The largest 10 holders included Third Security, LLC, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, BB BIOTECH AG, MILLENNIUM MANAGEMENT LLC, BlackRock Fund Advisors, First Eagle Investment Management, LLC, Sectoral Asset Management Inc, FMR LLC, and STATE STREET CORP. This page lists 137 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.